Skip to main content
PMC home page
Gut logoLink to Gut
. 1969 Jul;10(7):565–568. doi: 10.1136/gut.10.7.565

Faecal flora of patients with ulcerative colitis during treatment with salicylazosulphapyridine.

E M Cooke
PMCID: PMC1552958  PMID: 4390007

Full text

PDF
567

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Asherson G. L., Holborow E. J. Autoantibody production in rabbits. VII. Autoantibodies to gut produced by the injection of bacteria. Immunology. 1966 Feb;10(2):161–167. [PMC free article] [PubMed] [Google Scholar]
  2. BOTTIGER L. E., MOLLERBERG H. Metabolic studies on azulfidine, azudimidine and one analogue. Acta Med Scand. 1959 Nov 18;165:241–244. [PubMed] [Google Scholar]
  3. Cooke E. M. A quantitative comparison of the faecal flora of patients with ulcerative colitis and that of normal persons. J Pathol Bacteriol. 1967 Oct;94(2):439–444. doi: 10.1002/path.1700940225. [DOI] [PubMed] [Google Scholar]
  4. Dragstedt L. R., Dack G. M., Kirsner J. B. CHRONIC ULCERATIVE COLITIS: A SUMMARY OF EVIDENCE IMPLICATING BACTERIUM NECROPHORUM AS AN ETIOLOGIC AGENT. Ann Surg. 1941 Oct;114(4):653–662. doi: 10.1097/00000658-194110000-00011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Felsen J., Wolarsky W. Bacillary Dysentery and Chronic Ulcerative Colitis in World War II. Science. 1947 Feb 21;105(2721):213–213. doi: 10.1126/science.105.2721.213. [DOI] [PubMed] [Google Scholar]
  6. HANNGREN A., HANSSON E., SVARTZ N., ULLBERG S. Distribution and metabolism of salicyl-azo-sulfapyridine. II. A study with S35-salicyl-azo-sulfapyridine and S35-sulfapyridine. Acta Med Scand. 1963 Apr;173:391–399. doi: 10.1111/j.0954-6820.1963.tb17422.x. [DOI] [PubMed] [Google Scholar]
  7. LENNARD-JONES J. E., LONGMORE A. J., JONES F. A. A comparative trial of salazopyrin, prednisone and hydrocortisone retention enemata in the out-patient treatment of left-sided colitis. Preliminary report. Proc R Soc Med. 1960 Aug;53:647–650. [PMC free article] [PubMed] [Google Scholar]
  8. LEVINE M. D., KIRSNER J. B., KLOTZ A. P. A new concept of the pathogenesis of ulcerative colitis. Science. 1951 Nov 23;114(2969):552–553. doi: 10.1126/science.114.2969.552. [DOI] [PubMed] [Google Scholar]
  9. MOERTEL C. G., BARGEN J. A. A critical analysis of the use of salicylazosulfapyridine in chronic ulcerative colitis. Ann Intern Med. 1959 Nov;51:879–889. doi: 10.7326/0003-4819-51-5-879. [DOI] [PubMed] [Google Scholar]
  10. SENECA H., HENDERSON E. Normal intestinal bacteria in ulcerative colitis. Gastroenterology. 1950 May;15(1 1):34–39. [PubMed] [Google Scholar]
  11. SVARTZ N. The treatment of ulcerative colitis. Gastroenterologia. 1956;86(5):683–688. doi: 10.1159/000200641. [DOI] [PubMed] [Google Scholar]
  12. WATKINSON G. Medical management of ulcerative colitis. Br Med J. 1961 Jan 21;1(5220):147–151. doi: 10.1136/bmj.1.5220.147. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. WEINSTEIN L. Bacteriologic aspects of ulcerative colitis. Gastroenterology. 1961 Feb;40:323–330. [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES